Crescent Capital BDC (CCAP) to Release Quarterly Earnings on Monday

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) will be announcing its earnings results after the market closes on Monday, November 11th. Analysts expect the company to announce earnings of $0.57 per share for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link.

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) last announced its earnings results on Monday, August 12th. The company reported $0.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.58 by $0.01. Crescent Capital BDC had a return on equity of 12.03% and a net margin of 51.61%. The business had revenue of $48.95 million for the quarter, compared to analysts’ expectations of $48.05 million. During the same period last year, the firm posted $0.56 earnings per share. On average, analysts expect Crescent Capital BDC to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Crescent Capital BDC Price Performance

NASDAQ CCAP opened at $18.30 on Friday. The company has a 50-day moving average price of $18.39 and a 200-day moving average price of $18.36. Crescent Capital BDC has a 52 week low of $15.91 and a 52 week high of $19.63. The company has a quick ratio of 1.40, a current ratio of 1.40 and a debt-to-equity ratio of 1.17. The firm has a market capitalization of $678.20 million, a P/E ratio of 6.65 and a beta of 0.81.

Crescent Capital BDC Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, October 15th. Shareholders of record on Monday, September 30th were issued a dividend of $0.42 per share. This is a boost from Crescent Capital BDC’s previous quarterly dividend of $0.09. This represents a $1.68 dividend on an annualized basis and a yield of 9.18%. The ex-dividend date of this dividend was Monday, September 30th. Crescent Capital BDC’s dividend payout ratio is currently 61.09%.

Analysts Set New Price Targets

CCAP has been the topic of several analyst reports. Wells Fargo & Company dropped their price target on shares of Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating on the stock in a research note on Wednesday, August 14th. LADENBURG THALM/SH SH started coverage on Crescent Capital BDC in a report on Monday, September 30th. They issued a “buy” rating and a $20.00 target price on the stock. Finally, Bank of America cut their price target on Crescent Capital BDC from $20.00 to $19.00 and set a “buy” rating for the company in a report on Thursday, August 15th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $19.00.

Read Our Latest Research Report on CCAP

Crescent Capital BDC Company Profile

(Get Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Read More

Earnings History for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.